Analysis and interpretation of the 2022 Global Cancer Statistics Report: cancer burden and epidemiological trends in China and the world

In February 2024, the International Agency for Research on Cancer (IARC) released the 2022 Global Cancer Statistics Report. In 2022, there were nearly 20 million new cancer cases and 9.7 million deaths. The report provides statistics on the incidence and mortality of 36 different types of cancer in...

Full description

Saved in:
Bibliographic Details
Main Author: WU Qi, FAN Bonan, LI Yan
Format: Article
Language:zho
Published: Editorial Office of Journal of Diagnostics Concepts & Practice 2025-04-01
Series:Zhenduanxue lilun yu shijian
Subjects:
Online Access:https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1752188766825-161598629.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849339325824630784
author WU Qi, FAN Bonan, LI Yan
author_facet WU Qi, FAN Bonan, LI Yan
author_sort WU Qi, FAN Bonan, LI Yan
collection DOAJ
description In February 2024, the International Agency for Research on Cancer (IARC) released the 2022 Global Cancer Statistics Report. In 2022, there were nearly 20 million new cancer cases and 9.7 million deaths. The report provides statistics on the incidence and mortality of 36 different types of cancer in 185 countries around the world, analyzing geographic, gender-based, and Human Development Index (HDI)-related differences. It also predicts the global burden of cancer disease by 2050. Demographic forecasts suggest that by 2050, the number of new cancer cases worldwide is expected to reach 35 million annually-an increase of 77% compared to 2022. Geographically, cancer incidence and mortality rates show significant regional disparities. In 2022, nearly half (49.2%) of the world's new cases and the majority (56.1%) of cancer deaths occurred in Asia. In terms of gender distribution, the overall cancer incidence and mortality rate among females were lower than those among males in 2022. With respect to HDI, the risk of developing cancer increases with higher HDI levels. In 2022, the top 5 newly diagnosed cancer cases worldwide are lung cancer, female breast cancer cancer, colorectal cancer, prostate cancer, gastric cancer in turn. There were nearly 2.5 million new lung cancer cases and over 1.8 million related deaths. Breast cancer in women accounted for 2.3 million new cases and nearly 670 000 deaths. Colorectal cancer, including anal cancer, had more than 1.9 million new cases and over 900 000 deaths. Prostate cancer recorded 1.5 million new cases and nearly 400 000 deaths. There were nearly 970 000 newly-diagnosed cases of gastric cancer and 660 000 related deaths. In China in 2022, lung cancer still ranks first in the cancer incidence spectrum in China, accounting for 22.0% of the total new cases of cancer in China. This proportion has further increased compared to 2018 data (17.9%), followed by colorectal cancer (10.7%), thyroid cancer (9.7%), liver cancer (7.6%), and gastric cancer (7.4%), which account for more than half of the total new cases in China (57.4%). This paper reviews the data sources and statistical methods used in the report, interprets the epidemiological trends of major cancer types, and analyzes the incidence and burden of major cancers prevalent in China, provi-ding an overview of their disease burden and epidemiological trends.
format Article
id doaj-art-16a322ece0804ddc9232bc5cbdcce217
institution Kabale University
issn 1671-2870
language zho
publishDate 2025-04-01
publisher Editorial Office of Journal of Diagnostics Concepts & Practice
record_format Article
series Zhenduanxue lilun yu shijian
spelling doaj-art-16a322ece0804ddc9232bc5cbdcce2172025-08-20T03:44:08ZzhoEditorial Office of Journal of Diagnostics Concepts & PracticeZhenduanxue lilun yu shijian1671-28702025-04-01240213514510.16150/j.1671-2870.2025.02.004Analysis and interpretation of the 2022 Global Cancer Statistics Report: cancer burden and epidemiological trends in China and the worldWU Qi, FAN Bonan, LI Yan01. Health and Wellness Industry Technology Research Institute,School of Foreign Studies,Yanshan University,Hebei Qinghuangdao 06600,China;2. Department of Social Medicine and Health Management,School of Public Health,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,ChinaIn February 2024, the International Agency for Research on Cancer (IARC) released the 2022 Global Cancer Statistics Report. In 2022, there were nearly 20 million new cancer cases and 9.7 million deaths. The report provides statistics on the incidence and mortality of 36 different types of cancer in 185 countries around the world, analyzing geographic, gender-based, and Human Development Index (HDI)-related differences. It also predicts the global burden of cancer disease by 2050. Demographic forecasts suggest that by 2050, the number of new cancer cases worldwide is expected to reach 35 million annually-an increase of 77% compared to 2022. Geographically, cancer incidence and mortality rates show significant regional disparities. In 2022, nearly half (49.2%) of the world's new cases and the majority (56.1%) of cancer deaths occurred in Asia. In terms of gender distribution, the overall cancer incidence and mortality rate among females were lower than those among males in 2022. With respect to HDI, the risk of developing cancer increases with higher HDI levels. In 2022, the top 5 newly diagnosed cancer cases worldwide are lung cancer, female breast cancer cancer, colorectal cancer, prostate cancer, gastric cancer in turn. There were nearly 2.5 million new lung cancer cases and over 1.8 million related deaths. Breast cancer in women accounted for 2.3 million new cases and nearly 670 000 deaths. Colorectal cancer, including anal cancer, had more than 1.9 million new cases and over 900 000 deaths. Prostate cancer recorded 1.5 million new cases and nearly 400 000 deaths. There were nearly 970 000 newly-diagnosed cases of gastric cancer and 660 000 related deaths. In China in 2022, lung cancer still ranks first in the cancer incidence spectrum in China, accounting for 22.0% of the total new cases of cancer in China. This proportion has further increased compared to 2018 data (17.9%), followed by colorectal cancer (10.7%), thyroid cancer (9.7%), liver cancer (7.6%), and gastric cancer (7.4%), which account for more than half of the total new cases in China (57.4%). This paper reviews the data sources and statistical methods used in the report, interprets the epidemiological trends of major cancer types, and analyzes the incidence and burden of major cancers prevalent in China, provi-ding an overview of their disease burden and epidemiological trends.https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1752188766825-161598629.pdf|cancer|global cancer statistics report|incidence|mortality
spellingShingle WU Qi, FAN Bonan, LI Yan
Analysis and interpretation of the 2022 Global Cancer Statistics Report: cancer burden and epidemiological trends in China and the world
Zhenduanxue lilun yu shijian
|cancer|global cancer statistics report|incidence|mortality
title Analysis and interpretation of the 2022 Global Cancer Statistics Report: cancer burden and epidemiological trends in China and the world
title_full Analysis and interpretation of the 2022 Global Cancer Statistics Report: cancer burden and epidemiological trends in China and the world
title_fullStr Analysis and interpretation of the 2022 Global Cancer Statistics Report: cancer burden and epidemiological trends in China and the world
title_full_unstemmed Analysis and interpretation of the 2022 Global Cancer Statistics Report: cancer burden and epidemiological trends in China and the world
title_short Analysis and interpretation of the 2022 Global Cancer Statistics Report: cancer burden and epidemiological trends in China and the world
title_sort analysis and interpretation of the 2022 global cancer statistics report cancer burden and epidemiological trends in china and the world
topic |cancer|global cancer statistics report|incidence|mortality
url https://www.qk.sjtu.edu.cn/jdcp/fileup/1671-2870/PDF/1752188766825-161598629.pdf
work_keys_str_mv AT wuqifanbonanliyan analysisandinterpretationofthe2022globalcancerstatisticsreportcancerburdenandepidemiologicaltrendsinchinaandtheworld